|
|
40
|
|
|
55511
|
|
|
THALIDOMIDE 50MG CAP (DIL/AHI)
|
|
|
THALIDOMIDE
|
|
|
THALIDOMIDE
|
|
|
30'S
|
|
|
C
|
|
|
62.25
|
|
|
2.08
|
|
|
50MG
|
|
|
CAPSULE
|
|
|
0
|
|
|
CAP
|
|
|
DIL
|
|
|
FRESENIUS KABI
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
30
|
|
|
No
|
|
|
9220
|
|
|
BIOLOGIC RESPONSE MODIFIER
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|